PDS Biotechnology Corporation
PDSB
$1.10
-$0.20-15.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.27M | 3.56M | 3.41M | 3.27M | 2.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.67M | 8.14M | 7.62M | 9.11M | 7.36M |
| Operating Income | -6.67M | -8.14M | -7.62M | -9.11M | -7.36M |
| Income Before Tax | -7.56M | -9.01M | -9.43M | -9.66M | -7.95M |
| Income Tax Expenses | 0.00 | -- | -- | -1.17M | 0.00 |
| Earnings from Continuing Operations | -7.56M | -9.01M | -9.43M | -8.49M | -7.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.56M | -9.01M | -9.43M | -8.49M | -7.95M |
| EBIT | -6.67M | -8.14M | -7.62M | -9.11M | -7.36M |
| EBITDA | -6.66M | -8.13M | -7.61M | -9.09M | -7.35M |
| EPS Basic | -0.15 | -0.19 | -0.21 | -0.21 | -0.21 |
| Normalized Basic EPS | -0.09 | -0.12 | -0.13 | -0.15 | -0.13 |
| EPS Diluted | -0.15 | -0.19 | -0.21 | -0.21 | -0.21 |
| Normalized Diluted EPS | -0.09 | -0.12 | -0.13 | -0.15 | -0.13 |
| Average Basic Shares Outstanding | 51.59M | 46.87M | 45.90M | 40.52M | 37.49M |
| Average Diluted Shares Outstanding | 51.59M | 46.87M | 45.90M | 40.52M | 37.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |